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More than 30 human disorders are caused by the expansion of simple sequence
DNA repeats, among which triplet repeats remain the most frequent. Most trinucleotide
repeat expansion disorders affect primarily the nervous system, through mechanisms
of neurodysfunction and/or neurodegeneration. While trinucleotide repeat tracts are
short and stably transmitted in unaffected individuals, disease-associated expansions
are highly dynamic in the germline and in somatic cells, with a tendency toward
further expansion. Since longer repeats are associated with increasing disease severity
and earlier onset of symptoms, intergenerational repeat size gains account for the
phenomenon of anticipation. In turn, higher levels of age-dependent somatic expansion
have been linked with increased disease severity and earlier age of onset, implicating
somatic instability in the onset and progression of disease symptoms. Hence, tackling
the root cause of symptoms through the control of repeat dynamics may provide
therapeutic modulation of clinical manifestations. DNA repair pathways have been firmly
implicated in themolecular mechanism of repeat lengthmutation. The demonstration that
repeat expansion depends on functional DNA mismatch repair (MMR) proteins, points
to MMR as a potential therapeutic target. Similarly, a role of DNA base excision repair
(BER) in repeat expansion has also been suggested, particularly during the removal of
oxidative lesions. Using a well-characterized mouse cell model system of an unstable
CAG•CTG trinucleotide repeat, we tested if expanded repeat tracts can be stabilized by
small molecules with reported roles in both pathways: cadmium (an inhibitor of MMR
activity) and a variety of antioxidants (capable of neutralizing oxidative species). We
found that chronic exposure to sublethal doses of cadmium and antioxidants did not
result in significant reduction of the rate of trinucleotide repeat expansion. Surprisingly,
manganese yielded a significant stabilization of the triplet repeat tract. We conclude that
treatment with cadmium and antioxidants, at doses that do not interfere with cell survival
and cell culture dynamics, is not sufficient to modify trinucleotide repeat dynamics in
cell culture.
Keywords: trinucleotide repeat, unstable DNA, mismatch repair, oxidative stress, cadmium, antioxidants, cell
culture model
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INTRODUCTION
The expansion of simple sequence DNA repeats has been
implicated in human disease (Hannan, 2018). Trinucleotide
repeat expansions, in particular, can cause severe neurological
and/or neuromuscular disorders, including Huntington disease
(HD), various spinocerebellar ataxias (SCA), fragile X syndrome
(FRAXA) and myotonic dystrophy type 1 (DM1) (Paulson,
2018). In non-affected individuals, repeat tracts are short and
genetically stable; in contrast affected individuals carry long
and unstable expansions. Expansion mutations generally result
in complex, multi-systemic phenotypes that are modulated
by the number of tandem repeats: generally, longer triplet
repeat alleles are associated with an earlier age at disease onset
and more severe disease symptoms (Usdin et al., 2015). The
majority of trinucleotide repeat diseases are caused by the
expansion of CAG•CTG repeats, which can either encode a
toxic polyglutamine tract in various proteins (Stoyas and La
Spada, 2018), or be transcribed into a non-coding CUG RNA
that interferes with the activity of key RNA-binding proteins and
RNA processing (Sicot and Gomes-Pereira, 2013; Swinnen et al.,
2020). Strikingly, all these conditions exhibit some element of
neurological dysfunction, demonstrating the vulnerability of the
central nervous system to triplet repeat expansionmutations (Orr
and Zoghbi, 2007).
Once within the disease-associated size range, trinucleotide
repeat alleles are highly unstable and liable to further expansion
in germline transmissions and in somatic tissues (Usdin et al.,
2015). Intergenerational instability frequently results in the
inheritance of a longer repeat allele by the offspring, relative
to the transmitting parent, hence explaining the phenomenon
of anticipation. Anticipation presents as the aggravation of
the disease symptoms and earlier age of onset in subsequent
generations, and it is a typical feature of most trinucleotide
repeat expansion disorders. Repeat instability in somatic tissues
is also expansion-biased and age-dependent. Notably, the largest
somatic expansions are often observed in the most severely
affected tissues, including the striatum in HD (Kennedy and
Shelbourne, 2000; Kennedy et al., 2003) and the skeletal muscle
in DM1 (Aslanidis et al., 1992; Ashizawa et al., 1993; Thornton
et al., 1994; Monckton et al., 1995). Age of onset and disease
progression are most likely governed by the number of inherited
repeats and the rate of repeat expansion in the soma. In support
of this view, higher individual-specific repeat expansion rates
have been directly linked with increased disease severity and
earlier age of onset in HD and DM1 (Swami et al., 2009; Morales
et al., 2012; Ciosi et al., 2019; Flower et al., 2019). Somatic repeat
expansion thus likely contributes toward the tissue specificity and
progressive nature of these disorders and presents as a potential
therapeutic target (Gomes-Pereira and Monckton, 2006; Castel
et al., 2010).
Given the relationship between repeat length and the
disease severity, deciphering the mechanisms of trinucleotide
repeat size mutation is relevant for understanding disease
progression, and it may provide an entry point for future
therapies. Disease-associated repeats form unusual secondary
non-B DNA structures (Khristich and Mirkin, 2020), which
may serve as substrates for DNA-binding proteins that mediate
repeat size gains by error-prone processing. Several DNA
repair pathways, which normally protect the genome against
damage by normal metabolic activities and environmental
factors, have been implicated in the mechanisms of repeat
instability (Usdin et al., 2015). Among those, DNA mismatch
repair (MMR) proteins are the strongest driver of repeat
expansions (Schmidt and Pearson, 2016; Jones et al., 2017).
Compelling evidence demonstrates that genetic inactivation of
MMR genes suppresses repeat instability in mouse models
of unstable CAG•CTG DNA (Manley et al., 1999; Van Den
Broek et al., 2002; Gomes-Pereira et al., 2004b; Savouret et al.,
2004; Foiry et al., 2006; Dragileva et al., 2009; Pinto et al.,
2013), while natural polymorphisms in MMR genes dictate
differences in repeat instability between mouse strains (Pinto
et al., 2013; Tomé et al., 2013). Similarly, polymorphisms
in human DNA mismatch repair genes are associated with
individual-specific differences in CTG•CAG repeat instability
(Morales et al., 2016; Ciosi et al., 2019; Flower et al., 2019)
and in disease course in HD, DM1 and SCA patients (Lee
et al., 2015, 2017, 2019; Bettencourt et al., 2016; Moss
et al., 2017) The first demonstration that inhibition of repeat
expansion could have therapeutic benefits was provided by
the genetic inactivation of MMR in HD mice, which not
only prevented accumulation of somatic mosaicism but also
delayed brain pathology (Wheeler et al., 2003). Full MMR
inactivation would however be unacceptable, given the expected
increase in cancer predisposition. Interestingly, different levels
of somatic instability between tissues have been correlated with
physiological differences in the expression of MMR proteins
(Mason et al., 2014). Therefore, it is conceivable that the
controlled modulation of the relative expression and/or activity
of the MMR complexes by non-toxic compounds would be
sufficient to decrease repeat expansion rates and reduce mean
repeat numbers in somatic cells. In this regard, partial inhibition
ofMMRby environmentally relevant concentrations of cadmium
increased the frequency of mutations of a mononucleotide
microsatellite, as well as frameshifts and base substitutions (Jin
et al., 2003). The consequences of cadmium exposure on the
dynamics of expanded trinucleotide DNA sequences remain to
be determined.
An additional layer of complexity is added by the suggested
role of oxidative stress and base excision repair (BER) in the
generation of repeat expansions, following the observation that
treatment of mouse and cell models of HD and FRAXA with
oxidants appeared to increase repeat expansion (Kovtun et al.,
2000, 2007; Entezam et al., 2010; Jonson et al., 2013). Conversely,
the neutralization of oxygen species by a synthetic radical
scavenger designed to target mitochondria appeared to reduce
somatic instability (Budworth et al., 2015) and improve HD-
associated pathology in a mouse model of the disease (Xun
et al., 2012; Polyzos et al., 2018). However, the toxicology
of this compound has not been fully investigated and its
therapeutic application is still uncertain. If oxidative stress
creates substrates for DNA mis-repair and repeat expansion, we
hypothesize that other canonical antioxidants would produce
similar protective effects.
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We have previously generated a cell culture model that
reproduces time-dependent, expansion-biased tissue-specific
somatic mosaicism (Gomes-Pereira et al., 2001; Gomes-Pereira
and Monckton, 2004) derived from a transgenic mouse model
of unstable CAG•CTG repeats (Fortune et al., 2000). In this cell
model, repeat expansion rates are not accounted for by different
cell proliferation rates (Gomes-Pereira et al., 2001), and repeat
size gains continue to occur even in the absence of cell division
and genome duplication (Gomes-Pereira et al., 2014). Here, we
have first investigated whether naturally occurring changes in the
expression levels of MMR correlate with the degree of somatic
mosaicism in homogenous cell cultures. Then, taking advantage
of our cell culture model, we have sought to explore the impact
of chronic exposure to cadmium (inhibitor of MMR activity),
hydrogen peroxide (oxidizing agent) and several antioxidants on
the dynamics of repeat expansions in somatic cells.
MATERIALS AND METHODS
Mouse Kidney Cell Culture, Chronic Metal
Ion Exposure and Antioxidant Treatment
The D2763Kc2 cell line is a clonal cell line derived from the
kidney of a 6-month-old Dmt-D mouse, which recreates high
levels of expansion-biased trinucleotide repeat instability in vitro
(Gomes-Pereira et al., 2001). Cell cultures were maintained and
passaged as previously described (Gomes-Pereira et al., 2001;
Gomes-Pereira and Monckton, 2004). For metal ion treatment
experiments a progenitor culture was split into multiple aliquots:
six replicate no-metal ion controls, and six replicate cultures
for each one of the compounds tested in this study (CdCl2,
CoCl2, MnCl2, and ZnSO4). Similarly, six replicate cultures
were continuously exposed to each individual antioxidant. All
cultures were maintained in parallel throughout the course of the
experiment. Control cultures were supplied with fresh medium
every 2 or 3 days and cells were passaged when confluent at a 1:40
dilution, approximately weekly. For treated cultures, each metal
compound and antioxidant was dissolved in complete growth
medium and supplied to the cells. Treated cultures were supplied
with fresh drug-supplemented medium every 2 to 3 days and the
cells were passaged just as the no-treatment controls. Control and
treated cells were cultured for a maximum of 73 days. Sublethal
doses were selected in previous survival assays, using increasing
concentrations of metal compounds and antioxidants.
SP-PCR Amplification of Transgenic
Trinucleotide Repeats
The degree of repeat length variation in each sample was assessed
by sensitive small-pool PCR (SP-PCR) analysis, performed as
previously described, using oligonucleotide primers DM-C and
DM-BR (Monckton et al., 1995; Gomes-Pereira et al., 2004a).
Each lane on the representative autoradiographs shown in the
figures contains the amplification products of a single SP-
PCR with ∼5 to 20 genomic equivalents of input DNA. Each
autoradiograph panel for an individual replicate culture is a
cropped image derived from a separate autoradiograph and
multiple images have been juxtaposed to aid comparison. The
degree of repeat length variation observed in treated and control
cell replicates at the time points indicated was schematically
represented by box plots. The top and bottom of the boxes
correspond to the third (Q3) and first quartiles (Q1), respectively
and the line across the box displays the median. The lines
extending from the top and the bottom of the boxes, include
values that fall inside the lower and upper limits: Q1-1.5(Q3-
Q1) and Q3+1.5(Q3-Q1), respectively. Themedian repeat length
gain was determined by measuring the degree of variation
in individual cultures and comparing this with the degree of
variation measured in the progenitor culture. Expansion rates
(in units of repeats gained per day) were calculated by dividing
the median repeat gain over the number of days in culture, as
previously described (Gomes-Pereira and Monckton, 2004).
Quantification and Statistical Analysis of
Repeat Size Variability
Single molecule SP-PCR analysis of 20 to 80 molecules per
culture was used to determine the median repeat length in
individual cultures. The median rates of expansion for each
individual culture were calculated relative to the measured
median repeat length in the progenitor culture at time zero, as
described before (Gomes-Pereira and Monckton, 2004). Median
expansion rates for each culture were calculated in terms of
repeat number change per day. To compare the median rates
of expansion between treated and control cultures we used the
non-parametric Kruskal-Wallis for multiple comparisons, in an
adaptation of the methods previously described (Gomes-Pereira
and Monckton, 2004). Statistical analyses were performed with
Prism 8 (GraphPad Software).
Protein Sample Preparation and Western
Blotting
Protein was extracted from cultured cells using EBC lysis buffer
(50mM Tris-HCl, 120mM NaCl, 0.5% (v/v) NP-40) containing
protease inhibitors (protease inhibitor cocktail for mammalian
tissues, Sigma, cat. no. P8340). Aliquots of 50 to 100 µg of whole
cell protein lysates were resolved by electrophoresis through a
NuPAGE 4 to 12% Bis-Tris Gel (Invitrogen, cat. no. NP0321)
and electroblotted onto Millipore Immobilon-P membranes
(Millipore, cat. no. IPVH00010) at 30V for 2 h in an XCellII Blot
Module (Novex, cat. no. EI9051) in NuPAGE Transfer Buffer
(Invitrogen, cat. no. NP0006-1). The membranes were blocked
overnight at 4◦C in 2.5% (w/v) or 5% (w/v) dried milk in TBST
(20mM Tris-HCl pH 7.6, 137mMNaCl, 0.06% (v/v) Tween-20),
then incubated for 2 h at room temperature in primary antibody.
Themembranes were washed four times for 15min each in TBST,
incubated for 1 h in secondary antibody at room temperature,
and washed four times for 15min each in TBST at room
temperature. Antibody binding was visualized using SuperSignal
West Pico Chemiluminescent Substrate (Pierce, cat. no. 34080).
PCNA was detected using 400 ng ml−1 rabbit anti-PCNA
polyclonal antibody (Santa Cruz Biotechnology, Cat# sc-7907,
RRID: AB_2160375) in 5% (w/v) dried milk in TBST. MSH2
was detected using 100 ng ml−1 mouse anti-MSH2 monoclonal
antibody (Millipore, Cat# NA27, RRID: AB_2266524) in 5%
Frontiers in Cellular Neuroscience | www.frontiersin.org 3 February 2021 | Volume 14 | Article 606331
Gomes-Pereira and Monckton Cadmium, Antioxidants and Unstable Trinucleotides
(w/v) dried milk in TBST. MSH3 was detected using 200 ng ml−1
goat anti-MSH3 polyclonal antibody (Santa Cruz Biotechnology,
Cat# sc-5690, RRID: AB_2145131) in 5% (w/v) dried milk in
TBST. MSH6 was detected using 250 ng ml−1 mouse anti-
MSH6 monoclonal antibody (BD Biosciences, Cat# 610919,
RRID: AB_398234) in 5% (w/v) dried milk in TBST. PMS2
was detected using 1 µg ml−1 mouse anti-PMS2 monoclonal
antibody (BD Biosciences, Cat# 556415, RRID: AB_396410) in
5% (w/v) dried milk in TBST. MLH1 was detected using 2.5 µg
ml−1 mouse anti-MLH1 monoclonal antibody (BD Biosciences,
Cat# 554073, RRID: AB_395227) in 5% (w/v) dried milk in
TBST. β-Tubulin was detected using 200 ng ml−1 rabbit anti-
β-tubulin polyclonal antibody (Santa Cruz Biotechnology, Cat#
sc-9104, RRID: AB_2241191). All proteins were detected using
20 ng ml−1 goat anti-rabbit (Santa Cruz Biotechnology, Cat# sc-
2004, RRID: AB_631746), 8 ng ml−1 goat anti-mouse (Jackson
ImmunoResearch Labs, Cat# 115-035-003, RRID: AB_10015289)
or 4 ng ml−1 donkey anti-goat (Santa Cruz Biotechnology, Cat#
sc-2020, RRID: AB_631728) horseradish peroxidase-conjugated
secondary antibodies diluted in 2.5% (w/v) or 5% (w/v) dried
milk in TBST. Incubation with Restore Western Blot Stripping
Buffer (Pierce, cat. no. 21059) for 20min at 40◦C was performed
to break antibody-antigen interactions and to subsequently re-
probe the same membrane. Densitometric analysis of protein
expression levels was performed using Kodak Digital Science 1D
software using exposures in the linear range of signal intensity.
RESULTS
Different Levels of Repeat Instability in
Cultured Cells Are Associated With
Variability in MMR Protein Expression
Different levels of somatic instability between tissues have been
correlated with variability in the expression of MMR and BER
proteins (Goula et al., 2009; Mason et al., 2014). However,
trinucleotide repeat size dynamics is governed by a complex
interplay between cis and trans-acting factors. It is therefore
difficult to directly attribute the variability in somatic mosaicism
between tissues to changes in the expression levels of DNA repair
proteins alone. To further elucidate the correlation between
MMR protein levels and repeat dynamics we derived single cell
clones from the progenitor D2763Kc2 culture (Gomes-Pereira
et al., 2001; Gomes-Pereira and Monckton, 2004) by limiting
dilution, and identified four subclones that exhibited different
degrees of somatic mosaicism, in spite of the similar proliferative
capacity, as revealed by their population doubling time (PDT):
while the CAG•CTG repeat tract was relatively stable in clones
1 and 2, it exhibited more pronounced repeat size variability
in clones 3 and 4 (Figure 1A, Table 1). Importantly, repeat
instability remained consistently low or high following further
subcloning, suggesting intrinsic differences in DNA metabolism
between the four clones selected (Figure 1B). Variability between
subclones may result from the accumulation of spontaneous
mutations and/or epigenetic modifications in cultured cells
(Wilson and Jones, 1983; Giraldo et al., 2007). It was our
hypothesis that some of these changes alter the MMR expression
levels, affect DNA metabolism and modify the dynamics of
trinucleotide repeats.
Consistent with a driving role of MMR proteins in triplet
repeat metabolism, western blot analysis revealed significantly
different steady-state levels MMR protein between clones
carrying repeats that were either stable (clones 1 and 2) or
unstable (clones 3 and 4) (Figure 1C, Supplementary Figure 1,
p < 0.001, Three-way ANOVA). Surprisingly, comparison of
individual protein levels revealed that the “unstable clones” 3
and 4 expressed significantly lower levels of MSH2, MSH3 and
MSH6, when compared to the “stable clones” 1 and 2 (Table 2).
In contrast, the levels of MSH2, MSH3 and MSH6 did not differ
between “stable clones” 1 and 2, neither did they differ between
“unstable clones” 3 and 4. We also found intriguing differences
in the levels of PMS2 and MLH1 between the two classes of
clones: PMS2 and MLH1 expression was also significantly lower
in clones showing extensive somatic mosaicism. However, the
ratios of MMR proteins were significantly different between
“unstable” and “stable” clones. In particular, high levels of
somatic mosaicism were associated with significantly higher
MSH3/MSH2 protein ratios in “unstable” clones (3 and 4),
relative to the “stable” clones (1 and 2). PMS2/MLH1 protein
ratios were also higher in “unstable” clones, but the difference did
not reach statistical significance (Figure 1C; Table 3).
In summary, our cell model system supports the view that
instability of CAG•CTG repeats is correlated with pathways of
DNA repair. Relative MMR proteins levels, in particular, appear
to be key determinants of repeat dynamics. Motivated by these
results we tested whether repeat length mutational dynamics can
be modified by the exposure to metal ions reported to interfere
with MMR activity (Jin et al., 2003).
Effects of Cadmium on the Dynamics of
Trinucleotide Repeats in Cultured Cells
To test if cadmium exposure was capable of modifying
trinucleotide repeat dynamics, we treated D2763Kc2 mouse
kidney cells to cadmium, as well as control divalent metal
ions (cobalt, manganese and zinc). We carefully selected
sublethal metal concentrations added to the cell culture medium
in survival assays (Supplementary Figure 2): 2.0µM was the
highest concentration of CdCl2, CoCl2 and MnCl2 that did
not affect the overall survival and PDT of D2763Kc2 cell
cultures chronically exposed for 7 days (Table 4). Although
the survival and PDT remained unaltered in the presence of
10µM of ZnSO4, we used a zinc concentration of 2.0µM
in our experiments, identical to the other metals. The similar
PDT between treated and control cultures excluded altered
cell division rates as a contributing factor to any changes in
trinucleotide repeat dynamics.
The original progenitor culture was split at time point zero
to generate control and treated cell cultures. For each metal
treatment six replicate cultures were established and maintained
in parallel with six untreated controls. Control and treated
D2763Kc2 cell cultures were then maintained for a period of
73 days, corresponding to 73 population doublings (PDT =
23.9 h). Following chronic exposure, the repeat length variability
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FIGURE 1 | Higher CAG•CTG repeat size variability is associated with higher MSH3/MSH2 protein ratios in homogenous single cell clones. (A) Representative
SP-PCR analyses of the expanded CAG•CTG trinucleotide repeat in D2763Kc2 cell clones. Single-cell clones were derived from the progenitor culture by limiting
dilution and grown for 20 population doublings (∼20 to 40 days). (B) Representative SP-PCRs of the expanded CAG•CTG repeat in sub-clones derived from four
selected D2763Kc2 clones showing different repeat dynamics. For clarity, only six representative sub-clonal cultures are shown. The scale on the right indicates the
DNA molecular weight markers converted into number of CAG•CTG repeats. (C) Quantification of MMR protein levels in selected D2763Kc2 clones. Independent
single cell clones were established from the same progenitor culture. Four clones were selected for analysis. Four protein lysates were collected from each clone,
electroblotted and probed with anti-MMR proteins. ß-Tubulin was used as loading control. The top graph shows the average protein levels relative to normalized
control clone 1. The bottom graph shows the average MMR protein ratios relative to normalized control clone 1. The error bars indicate ± SEM. Statistically significant
changes are indicated (*p < 0.05, **p < 0.01, ***p < 0.0015; Two-way ANOVA, Tukey post-hoc correction for multiple comparisons).
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TABLE 2 | Statistical comparison of MSH6, MSH3, MSH2, PMS2 and MLH1


































































































*p < 0,05; **p < 0.01; ***p < 0.001; n.s., non-significant; Two-way ANOVA, Tukey’s
multiple comparison test.
of each chemically treated culture was assessed by sensitive SP-
PCR techniques and compared to the progenitor and control
cultures grown in the absence of the metal (Figure 2). The
transgenic repeat length continued to expand rapidly in control
cells, with a median expansion rate of 1.0 repeat per day. Metal-
treated cultures displayed median expansion rates varying from
0.81 to 1.18 repeats per day. We determined if the median
expansion rates measured in control and treated cultures were
statistically different, using single molecule analyses as previously






















































































*p < 0,05; n.s., non-significant; Two-way ANOVA, Tukey’s multiple comparison test.
described (Gomes-Pereira and Monckton, 2004; Gomes-Pereira
et al., 2014). Cadmium exposure did not change the expansion
rate of the trinucleotide repeat sequence, which continued to
expand at a median expansion rate of 1.13 repeats per day that
did not differ significantly from control cells (p = 0.168, Kuskal-
Wallis test). Surprisingly, manganese-treated cells displayed a
median repeat expansion of 0.81 repeats per day, representing
a significant reduction of ∼ 20% relative to untreated cells (p
= 0.026, Kuskal-Wallis test), ∼28% relative to cadmium-treated
cultures (p = 0.0023, Kuskal-Wallis test) and ∼ 31% relative to
zinc-treated cultures (p= 0.0021, Kuskal-Wallis test).
It is conceivable than rather than affecting the median repeat
length in culture, the exposure to cadmium changes the spread
of repeat sizes carried by individual cells. We used the variance
of repeat sizes in each replicate culture as a measure of repeat
size dispersion, and tested if the chronic exposure to metals
caused significant changes between treatments. In addition to
the reduction in the expansion rate, treatment with manganese
also decreased repeat size heterogeneity relative to controls
(2226.0 ± 301.0, manganese; 4058.9 ± 26.4, control; p = 0.030,
Kuskal-Wallis test). In conclusion, while cadmium did not
detectably modify the somatic instability of CAG•CTG repeats
in D2763Kc2 mouse kidney cells, manganese appeared to slow
down trinucleotide repeat expansion in culture.
Effects of Antioxidants on the Dynamics of
Trinucleotide Repeats in Cultured Cells
To determine if antioxidants are capable of slowing down
repeat expansion in our cell model of unstable trinucleotide
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Control 73 73 23.9 - 1.00 NAc NAc
Manganese [2µM] 73 73 23.9 0% 0.81 −19% 0.026
Cobalt [2µM] 73 73 23.9 0% 1.01 +1% 0.974
Zinc [2µM] 73 73 23.9 0% 1.18 +18% 0.158
Cadmium [2µM] 73 73 23.9 0% 1.13 +13% 0.168
H2O2 [20µM] 73 73 23.9 0% 0.92 −8% 0.612
Ethanol [0.1%] 73 73 23.9 0% 1.07 +7% 0.774
Melatonin [20µM in 0.1% ethanol] 73 73 23.9 0%e 0.98 −8%e 0.528e
Ascorbic Acid [200µM] 73 68 25.8 +8% 1.10 +10% 0.603
Trolox C [500µM in 0.1% ethanol] 73 73 23.9 0%e 1.07 0%e 0.511e
aPD, population doublings.
bPDT, population doubling time.
cNA, not applicable.
dTwo-tailed Kruskal-Wallis test.
eRelative to ethanol vehicle controls.
FIGURE 2 | Chronic exposure to cadmium and other divalent metals does not greatly affect the dynamics of expanded CAG•CTG repeats. (A) The autoradiographs
show representative SP-PCR analyses of expanded CAG•CTG repeats. Replicate D2763Kc2 cell cultures (1 to 6) were exposed to 2µM of the metal compounds
over a period of 73 days, corresponding to 73 population doublings. The progenitor culture from which all cells were derived at day zero is shown. The scale on the
right displays the molecular weight markers converted into CTG repeat numbers. (B) The boxplots represent the degree of repeat length variability in treated and
control cells following chronic exposure. Differences between the median expansion rates of control and treated cell cultures were analyzed and the p-values
presented (Kruskal-Wallis test for multiple comparisons; *p < 0.05). A significant reduction in the repeat expansion rate was detected in the presence of manganese.
sequences, we treated D2763Kc2 cells over 73 days with a
panel of well-known primary antioxidants that exhibit efficient
radical-scavenging activity: melatonin, ascorbic acid and Trolox
C (an analog of vitamin E) (Simunkova et al., 2019). In
parallel, long-term exposure to hydrogen peroxide was used to
mimic conditions of chronic oxidative stress. As in previous
experiments, we selected the highest dose of hydrogen peroxide
and antioxidants that did not interfere with cell survival and PDT
(Supplementary Figure 3, Table 4). The dynamics of expanded
CAG•CTG repeats in D2763Kc2 cells was not affected by chronic
exposure to hydrogen peroxide and antioxidants (Figure 3). Cells
treated with antioxidants continued to expand at a rate of 0.91 to
1.10 repeats per day, which was not statistically different from the
rate measured in untreated cells, or in cells exposed to ethanol
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FIGURE 3 | Continuous treatment with antioxidant molecules does not prevent repeat size expansions in a cell culture model system of unstable CAG•CTG repeats.
(A) Representative SP-PCR analyses of the expanded CAG•CTG trinucleotide repeat in D2763Kc2 cells cultured for 73 population doublings (corresponding to 68 to
73 days) in the presence of hydrogen peroxide, ethanol (control solvent) or three different antioxidants. Six replicate D2763Kc2 cultures (1 to 6) were analyzed. The
progenitor culture from which all cells were derived at day zero is also shown. The scale on the right displays the molecular weight markers converted into CTG repeat
numbers. (B) The boxplots show the degree of repeat length variability in treated and control cells at the end of the treatment. None of the treatments tested resulted
in a significant change of the repeat expansion rate. p-values are indicated (Kruskal-Wallis test for multiple comparisons).
(solvent control for melatonin and Trolox C). We then tested if
repeat size variability (rather than repeat median) was different
between treatments. Interestingly the variance of repeat sizes
following ascorbic acid exposure was significantly lower relative
to untreated control cells (2713.3 ± 129.7, ascorbic acid; 3390.7
± 195.7, control; p = 0.0411, Kruskal-Wallis test). The other
treatments did not change significantly the spread of repeat sizes.
Together our data suggest that the dynamics of the expanded
CAG•CTG sequence is not greatly altered by oxidizing agents
or antioxidants in our cell culture model system of unstable
triplet repeats.
DISCUSSION
Our main aim was to determine if the exposure to chemicals
reported to reduce MMR activity and oxidative stress could
modify the dynamics of expanded trinucleotide repeats. Our
findings reveal that chronic exposure of our cell culture models
of unstable CAG•CTG trinucleotides to sub-lethal doses of
cadmium (a putative MMR inhibitor), as well as melatonin,
ascorbic acid and Trolox C (well-known antioxidants) did not
affect the somatic repeat expansion rate. We have however
identified manganese, as a divalent metal that appears capable
of stabilizing the repeat, and ascorbic acid as a water-soluble
antioxidant that appears to reduce repeat size variability without
affecting the overall net repeat expansion rate.
We first determined if the levels of somatic mosaicism
correlated with MMR protein levels in cell culture. Cell clones
displaying high degrees of repeat size variability did not
express higher absolute levels of MMR proteins, but showed
differences in the relative expression of MMR proteins: in
particular, the clones exhibiting high levels of somatic mosaicism
showed significantly higher MSH3/MSH2 protein ratios. The
analysis of four individual clones produced results that are
in agreement with the reported role of individual MMR
proteins on the dynamics of CAG•CTG repeats. Ablation
of MMR genes in different mouse models carrying unstable
CAG•CTG sequences revealed that the deficiency of specific
genes (Msh2, Msh3, Mlh1, Mlh3, and Pms2) can suppress
somatic and/or germline instability (Manley et al., 1999; Van
Den Broek et al., 2002; Gomes-Pereira et al., 2004b; Pinto
et al., 2013; Schmidt and Pearson, 2016). These effects are
gene-specific, since Msh6 deficiency did not result in repeat
stabilization and could even promote repeat expansion (Van
Den Broek et al., 2002; Foiry et al., 2006; Dragileva et al.,
2009). The opposing effects of Msh3 and Msh6 inactivation is
consistent with the proposal that the dynamics of expanded
trinucleotides could be dictated by the recognition and binding
of two partially redundant MutS complexes: the MSH2•MSH3
complex promoting repeat expansion; and the MSH2•MSH6
complex mediating repeat deletion (Van Den Broek et al.,
2002). Importantly, the stability of individual MSH3 and
MSH6 proteins depends on their heterodimerization with
MSH2. Hence, the low levels of MSH6 protein measured in
“unstable” clones may provide more MSH2 to bind and stabilize
MSH3, increasing the formation of expansion-promoting
MSH2•MSH3 heterodimers.
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We then sought to explore new pharmacological means to
modify repeat dynamics. The chronic exposure of D2763Kc2
kidney cells to cadmium over long periods of time, at doses that
appeared to inhibit MMR in human cell extracts by ∼3–30%
(Jin et al., 2003), did not detectably alter trinucleotide repeat
dynamics, leaving expansion rates unchanged. We conclude that
low, sub-lethal doses of cadmium do not perturb the processing
of unstable trinucleotide repeats. However, we did not directly
assess MMR activity in our treated cells and it is possible
that, in contrast with the acute exposure protocols previously
reported (Lützen et al., 2004), the chronic treatments described
here may have triggered an adaptative response to cadmium
exposure that obviated the inhibitory effect of acute exposure to
cadmium on MMR. Alternatively, the lack of a stabilizing effect
of cadmium might instead be due to the inability of this metal to
target exclusively MMR components involved in the expansion
mechanism. Cadmium is reported to inhibit the endonuclease
activity of the MLH1•PMS2 complex (Sherrer et al., 2018)
and PMS2 deficiency is associated with reduced CAG•CTG
expansion rates (Gomes-Pereira et al., 2004b). However, unlike
MLH3 (Pinto et al., 2013), PMS2 is not essential for expansion
(Gomes-Pereira et al., 2004b). Thus, it is possible that any
inhibitory effect on MLH1•PMS2 activity is compensated for
by the MLH1•MLH3 complex, although given that PMS2
and MLH3 are highly related orthologs, MLH1•MLH3 may
be similarly inhibited by cadmium. Cadmium also appears
to non-specifically alter the binding and ATPase activity of
the MSH2•MSH6 complex (Clark and Kunkel, 2004; Banerjee
and Flores-Rozas, 2005; Wieland et al., 2009). However, the
MSH2•MSH6 complex is not required for CAG•CTG repeat
expansion (Van Den Broek et al., 2002) and it is possible that the
MSH2•MSH3 heterodimer, that is required for expansion (Van
Den Broek et al., 2002), is not affected by cadmium. Alternatively,
through its broader non-specific impact on a variety of DNA
repair enzymes (Wieland et al., 2009), cadmium may alter other
aspects of the CAG•CTG expansion pathway and compensate for
any direct effect on the MMR components of expansion.
Surprisingly, manganese appeared capable of reducing the
expansion rate and repeat size variability of expanded CAG•CTG
repeats, without changing cell population dynamics. Manganese
promotes MLH1•PMS2 endonuclease activity (Kadyrov et al.,
2006). Given the implication of MLH1 and PMS2 in the control
of CAG•CTG repeat dynamics in mice (Gomes-Pereira et al.,
2004b; Pinto et al., 2013) and in humans (Ciosi et al., 2019),
it is likely that interfering with the activity of this MMR
heterodimer will impact repeat dynamics. Alternatively, the
effect of manganese on trinucleotide repeat dynamics might be
mediated by impaired fidelity and trans-lesion DNA synthesis
(Hays and Berdis, 2002; Vashishtha et al., 2016).
The chronic exposure of D2763Kc2 kidney cells to multiple
antioxidants, at doses that do not interfere with global population
dynamics, did not stabilize the expanded CAG•CTG repeat
carried by these cells. Ascorbic acid however, appeared capable
of reducing repeat size variability, lowering somatic mosaicism
in culture. Trinucleotide repeat dynamics is the combined result
of stepwise expansions and contractions of a limited number
of repeat units (Higham et al., 2012). Therefore, it is possible
to reduce repeat size variability independent of net expansion
size, through changes in the relative frequency of expansion
and contraction events, and/or changes in the magnitude of
stepwise mutations.
Overall, our data do not support the use of antioxidant
scavenging systems to suppress somatic expansion. In agreement
with these results, we previously showed that chronic exposure
of D2763Kc2 to hydrogen peroxide cells did not induce repeat
expansions (Gomes-Pereira and Monckton, 2004). However, our
observations contrast with findings in HD fibroblasts (Kovtun
et al., 2004) and mouse embryonic stem cells (Jonson et al.,
2013) where hydrogen peroxide treatment appeared to increase
expansion rates. While we have treated multiple replicates
continuously (73 days) with low doses of hydrogen peroxide
(20µM), in an attempt to mimic chronic environmental stress,
others have carried out acute exposure (30min) with higher
doses (150 to 1,000µM), leaving the cells to recover for days
before repeat length assessment (Kovtun et al., 2004; Jonson
et al., 2013). It is also unclear if these experiments were
replicated to control for stochastic variation and/or clonal
selection and cell-expansion events. Alternatively, in the absence
of direct measures of oxidative damage in our experiments, we
cannot exclude the possibility that chronic exposure to oxidants
triggered an adaptative response to reduce DNA damage and
minimize genotoxicity.
In summary, chronic exposure to cadmium and antioxidants
did not stabilize an expanded trinucleotide repeat in our cell
culture model system. We thus anticipate that more efficacious
and specific inhibitors of the expansion pathway may need to
be rationally designed to modify repeat dynamics safely and
efficiently for therapeutic benefit.
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Supplementary Figure 1 | Western blot detection of MMR proteins in D2763Kc2
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Supplementary Figure 2 | Cell survival in the presence of metal compounds.
Semi-logarithmic representation of the mean cell survival (±SD) of D2763Kc2
duplicate cultures exposed to increasing concentrations of metal compounds,
over a period of seven days. Concentrations were plotted using a logarithmic
scale. Cell survival was assessed by a trypan blue exclusion assay.
Supplementary Figure 3 | Cell survival in the presence of oxidants and
antioxidants. Semi-logarithmic representation of the mean cell survival (±SD) of
D2763Kc2 duplicate cultures exposed to increasing concentrations of hydrogen
peroxide and multiple antioxidant compounds, over a period of seven days.
Ethanol was used as control vehicle. Concentrations were plotted using a
logarithmic scale. Cell survival was assessed by a trypan blue exclusion assay.
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